For the period quarter ended 2016-12-31, Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) had $0.21 as the estimate of Earning Per Share(EPS). $0.21 and $0.21 were given as the EPS estimates for between seven and 30 days. But for 60 and 90 days, the EPS estimates were $0.21 and $0.21 respectively while 0% is the percentage change in EPS estimations from 7 days ago.
The last 7 days had 0 and 0 as the number of EPS adjustments. 2, 2, 2 and 1 were the number of up reconsiderations of EPS in the last 30, 60, 90 and 120 days.
The following were the number of down revisions of EPS in the last 30, 60, 90 and 120 days, 3, 3, 3 and 4.
The last 18 days had a 1 and 4 as the number of EPS revisions up and down
Before the announcement of actual earnings for the period ended 2, the mean EPS estimate is $0.21 whose calculation is in consideration of 6 EPS estimates. However, $0.18 was the actual EPS as announced on 2016-08-02. $0.05 and 38.46% is the EPS surprise amount in per share dollar and percentage terms while $0.02 is the standard deviation of all EPS estimates before the reporting of standard variation of all EPS estimates.
Quarterly Sales Estimates
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has $58.922 as the arithmetic mean of all Annual sales estimates whereas $58.655 is the median of all yearly sales estimates. 4 is what the company’s analysts use calculate the estimate for the fiscal year 2016 with the $60.97 being the highest and $57.41 the lowest. Nevertheless, $1.529 reflects the average difference of all Annual sales estimates.
The covering of stock by analysts who have increased and decreased their sales is on an estimation of one week, one month an three months. The one week’s estimation are 4 and 4 with 0% being the percentage change of the mean estimate.
4 and 4 are for one month ago with a -1.162% change of the mean estimate.
Sales estimate since three month ago are 4 and 4 whereas the -1.616% is the percentage change of the mean estimate.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...